Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children

March 26, 2012 updated by: Carlos Teran, Centro Pediatrico Albina de Patino

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children: A Randomized Double-blind Trial

The purpose of this study is to determine the effect of probiotic yogurt in acute watery diarrhea in children. The investigators will compare the effect of two different probiotics products.

Study Overview

Detailed Description

Background: Acute Gastroenteritis is one of the most and frequent disease in the childhood, considering the advances in treatment, Lactobacillus Rahmnosus has being well described as a probiotic who reduces the number of days of hospitalization and also de the severity.

Objectives: To evaluate the effect of the probiotic yogurt in the treatment of children who are between 10 months and 3 years old with acute non-dysenteric diarrhea.

Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive Lactobacillus Rahmnosus in a yogurt presentation and the other one will receive Sacharomyces boulardii in a lyophilized form ; the parameters of evaluation are going to be the number of diarrhea stools by day, number of vomiting episodes, hours with fever, nutritional and immunization state.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cochabamba, Bolivia, 0866
        • Centro Pediatrico Albina Patino

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 months to 3 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All acute diarrhea

Exclusion Criteria:

  • Severe malnourishment
  • Severe dehydration
  • Systemic infections

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: probiotic
Probiotic product with Sacharomices Boulardii
Lyophilized probiotic, containing 250 mg per sachet dosage to about 2 times a day for 5 days.
Other Names:
  • Florestor
ACTIVE_COMPARATOR: probiotic yogurt
Yogurt with Lactobacilus Rhamnonsus strain spp
Lactobacilus Rhamnonsus 100000000 UFC per mL. Dosage 50 mL twice daily fo 5 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of diarrhea
Time Frame: five days
participants will be followed for the duration of hospital stay, an expected average of 5 days
five days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of fever
Time Frame: five days
participants will be followed for the duration of hospital stay, an expected average of 5 days
five days
duration of vomiting
Time Frame: five days
participants will be followed for the duration of hospital stay, an expected average of 5 days
five days
duration of hospitalization
Time Frame: five days
participants will be followed for the duration of hospital stay, an expected average of 5 days
five days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giuseppe E Grandy, MD MSc, Centro Pediatrico Albina Patino
  • Study Chair: Sdenka Jose, MD, Centro Pediatrico Albina Patino

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (ACTUAL)

August 1, 2011

Study Completion (ACTUAL)

February 1, 2012

Study Registration Dates

First Submitted

October 29, 2011

First Submitted That Met QC Criteria

March 26, 2012

First Posted (ESTIMATE)

March 27, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

March 27, 2012

Last Update Submitted That Met QC Criteria

March 26, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Gastroenteritis

Clinical Trials on Placebo probiotic

3
Subscribe